Tophaceous pseudogout in a patient undergoing peritoneal dialysis

被引：0

作者：

Jimbo, Rika ^{[1
]}

Iida, Hidekazu ^{[2
]}

Ishibashi, Yoshitaka ^{[2
]}

机构：

[1] Odaira Mem Tokyo Hitachi Hosp, Dept Internal Med, Bunkyo Ku, 3-5-7 Yushima, Tokyo, Japan

[2] Japanese Red Cross Med Ctr, Dept Nephrol, Shibuya Ku, Tokyo, Japan

来源：

CEN CASE REPORTS | 2014年 / 3卷 / 02期

关键词：

Pseudogout; Calcium pyrophosphate dihydrate deposition disease; Chronic kidney disease; Peritoneal dialysis;

D O I：

10.1007/s13730-013-0107-9

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Calcium pyrophosphate dihydrate deposition disease (pseudogout) is a crystal arthritis characterized by pyrophosphate dihydrate crystal deposition in the articular cartilage or synovium. In chronic kidney disease patients, the major causes of crystal arthritis are calcium oxalate crystals and basic calcium phosphate crystals. However, pseudogout is apparently infrequent among such patients. This report describes a rare case of tophaceous pseudogout (tumoral form of pseudogout) involving the hip joint in a peritoneal dialysis patient, as revealed by CT scan and synovial fluid aspiration. Fluid aspiration and oral NSAIDs improved the clinical symptoms. This report is the first to describe tophaceous pseudogout in a peritoneal dialysis patient, which suggests that pseudogout should be suspected in dialysis patients with unexplained arthritis.

引用

页码：148 / 151

页数：4

共 13 条

[11]

Yildiz N, 2008, CLIN NEPHROL, V70, P424

[12] EULAR recommendations for calcium pyrophosphate deposition. Part II: Management [J].

Zhang, W. ;

Doherty, M. ;

Pascual, E. ;

Barskova, V. ;

Guerne, P-A ;

Jansen, T. L. ;

Leeb, B. F. ;

Perez-Ruiz, F. ;

Pimentao, J. ;

Punzi, L. ;

Richette, P. ;

Sivera, F. ;

Uhlig, T. ;

Watt, I. ;

Bardin, T. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) :571-575

[13] European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis [J].